Dimension Tbi Flex and Dbi Flex Reagent Cartridges and Tbi/Dbi Calibrator
Diazo Colorimetry, Bilirubin. 510(k) K060628, from Dade Behring, Inc. (Newark, DE). Product code CIG, class 2.
As of Nov 18, 2026, K060628 is an FDA 510(k) held by Dade Behring, Inc., substantially equivalent on Apr 6, 2006 after 28 days, with 1 recall tied to it in FDA's recall database.
- Review time: 28 days
- Recalls: 1
- Cited as a predicate by: 1 device
TBI Flex® reagent cartridge: The TBI method for the Dimension® clinical chemistry system is an in vitro diagnostic test intended to quantitatively measure total bilirubin in human serum and plasma. Measurements of total bilirubin are used in the diagnosis and treatment of liver, hemolytic, hematological, and metabolic disorders, including hepatitis and gallbladder disease.
- Dimension (Tm) Clinical Chemistry SystemK861700 · E.I. Dupont DE Nemours & Co., Inc. · Jun 11, 1986
- Meth./Cali./Intru. Check for The Dimension SystemK862359 · E.I. Dupont DE Nemours & Co., Inc. · Aug 19, 1986
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
| Started | Recall | Status |
|---|---|---|
| Feb 13, 2020 | Z-1540-2020Bilirubin assays may exhibit a positive bias with patients on eltrombopag therapy | Terminated |
- Atellica CH Diazo Total Bilirubin (D_TBil)K251998 · Siemens Healthcare Diagnostics, Inc. · Feb 27, 2026
- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · Dec 29, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Mar 9, 2006
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files